BRIEF-Coherus Oncology Inc - Announces Agreement With Janssen - SEC Filing

Reuters
Feb 04
BRIEF-Coherus Oncology Inc - Announces Agreement With Janssen - SEC Filing

Feb 4 (Reuters) - Coherus Oncology Inc CHRS.O:

  • COHERUS ONCOLOGY INC - ANNOUNCES AGREEMENT WITH JANSSEN - SEC FILING

  • COHERUS ONCOLOGY INC: JANSSEN WILL PROVIDE PASRITAMIG TO COMPANY, WHO WILL BE SPONSOR OF PHASE 1B CLINICAL TRIAL

  • COHERUS ONCOLOGY INC - JANSSEN AND CO EACH RETAIN ALL COMMERCIAL RIGHTS TO THEIR RESPECTIVE COMPOUNDS

Source text: [ID:n0001104659-26-010065]

Further company coverage: CHRS.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10